Company profile

Anjarium Biosciences AG

Anjarium Biosciences AG is a genetic medicines company focused on creating and delivering a new generation of targeted gene therapies to patients. Anjariums versatile platform builds on novel therapeutic payloads and delivery technologies, with the aim to unlock the full potential of gene therapy.

Anjarium Biosciences AG

Source: startup.ch

Highlights

Innosuisse CertificateInnosuisse Certificate

More news about Anjarium Biosciences AG

13.01.2023 15:00

Seasoned executives to drive startups in the next phase
  • Support
    Please login or
    register to use the
    awards follow feature
    30.12.2022 11:15

    Experienced members on startups' board
  • Support
    Please login or
    register to use the
    awards follow feature
    16.12.2022 09:00

    Newly hired executives to boost their company’s growth
  • Support
    Please login or
    register to use the
    awards follow feature
    20.07.2022 10:16

    Executive seats taken at six startups
  • Support
    Please login or
    register to use the
    awards follow feature
    29.06.2022 16:00

    New C-Suite leaders assume responsibility to boost startup growth
  • Support
    Please login or
    register to use the
    awards follow feature
    28.01.2022 15:00

    Schlieren biotech unlocks the potential of gene therapy
  • Support
    Please login or
    register to use the
    awards follow feature
    16.09.2021 09:00

    Anjarium Biosciences Raises CHF 55.5 Million Series A Financing
  • Financing
    Please login or
    register to use the
    awards follow feature
    14.09.2020 08:32

    Strong Swiss delegation at Bio Europe
  • Background
  • Support
    Please login or
    register to use the
    awards follow feature
    19.05.2020 17:06

    Eleven Swiss start-ups on the virtual BIO Digital stage
  • Support
    Please login or
    register to use the
    awards follow feature
    Anjarium Biosciences AG

    Founded
    2016

    Kanton
    ZH

    Homepage

    rss